Fatty Acid Oxidation Markers – Definition & Overview

What Are Fatty Acid Oxidation Markers?

Fatty acid oxidation markers are biochemical parameters measured in blood, urine, or tissue that provide information about the efficiency and integrity of fatty acid oxidation in the human body. Fatty acid oxidation – commonly referred to as beta-oxidation – is a fundamental metabolic process in which fatty acids are progressively broken down inside the mitochondria to produce energy in the form of ATP. When this process is disrupted, specific markers accumulate in the body, enabling clinicians to identify and characterize the underlying defect.

Biological Background of Fatty Acid Oxidation

Fatty acids serve as a major energy source, particularly during prolonged fasting, physical exercise, and in high-energy-demand organs such as the heart and skeletal muscles. The process of fatty acid oxidation involves several key steps:

• Activation of the fatty acid to acyl-CoA in the cytoplasm
• Transport into the mitochondria via the carnitine shuttle system
• Stepwise oxidative degradation within the mitochondrial matrix (beta-oxidation)
• Generation of acetyl-CoA, which enters the citric acid cycle
• Final production of ATP for cellular energy needs

When any of these steps is impaired, fatty acids and their intermediate metabolites accumulate, potentially causing severe, life-threatening metabolic conditions.

Key Fatty Acid Oxidation Markers

Acylcarnitines

Acylcarnitines are the most commonly measured fatty acid oxidation markers. They are intermediates formed during the transport of fatty acids into mitochondria. Elevated acylcarnitine levels in blood or urine indicate a blockage in the beta-oxidation pathway. Using tandem mass spectrometry (MS/MS), specific acylcarnitine profiles can be linked to particular enzyme deficiencies.

Urinary Organic Acids

When fatty acid oxidation is disrupted, specific organic acids accumulate in the urine, including dicarboxylic acids such as adipic acid, suberic acid, and sebacic acid. These can be detected and quantified using gas chromatography-mass spectrometry (GC-MS), providing valuable diagnostic information.

Free Fatty Acids and Ketone Bodies

During fasting or periods of increased energy demand, free fatty acids are mobilized from fat tissue. If they cannot be adequately oxidized, an imbalance develops between elevated free fatty acids and inappropriately low ketone bodies in the blood – a hallmark finding in fatty acid oxidation disorders.

Carnitine and Acylcarnitine Ratio

A reduced free carnitine level combined with elevated acylcarnitines (reflected in a low free-to-total carnitine ratio) is a sensitive indicator of fatty acid oxidation disorders and can point to secondary carnitine deficiency.

Creatine Kinase (CK)

In fatty acid oxidation disorders that primarily affect muscle tissue (e.g., VLCAD deficiency), elevated creatine kinase (CK) levels in the blood may signal muscle damage or rhabdomyolysis.

When Are Fatty Acid Oxidation Markers Measured?

Testing for fatty acid oxidation markers is indicated in the following clinical situations:

• Suspected inherited fatty acid oxidation disorders (e.g., MCAD deficiency, VLCAD deficiency, LCHAD deficiency)
• Newborn screening programs for early detection of metabolic diseases
• Unexplained hypoglycemia, especially in the fasting state
• Sudden liver dysfunction or cardiomyopathy of unknown origin
• Muscle weakness or recurrent episodes of rhabdomyolysis
• Therapeutic monitoring in patients with known fatty acid oxidation disorders

Diagnostic Methods

Several laboratory techniques are used to detect and quantify fatty acid oxidation markers:

• Tandem mass spectrometry (MS/MS): The gold standard for acylcarnitine profiling from dried blood spots or plasma
• Gas chromatography-mass spectrometry (GC-MS): Used for the analysis of urinary organic acids
• Enzyme activity assays: Direct measurement of beta-oxidation enzyme activity in leukocytes or fibroblasts
• Molecular genetic testing: Identification of gene mutations causing fatty acid oxidation disorders

Clinical Relevance and Associated Disorders

Fatty acid oxidation markers are central to diagnosing inherited metabolic diseases, including:

• MCAD deficiency (Medium-Chain Acyl-CoA Dehydrogenase deficiency): The most common fatty acid oxidation disorder
• VLCAD deficiency (Very-Long-Chain Acyl-CoA Dehydrogenase deficiency): Primarily affects the heart and musculature
• LCHAD deficiency (Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase deficiency): May cause severe liver disease
• Carnitine transporter defect: Impaired cellular uptake of carnitine
• Glutaric aciduria type II: Combined defect affecting both fatty acid and amino acid oxidation

Beyond rare inherited disorders, fatty acid oxidation markers are also of growing scientific interest in the context of heart disease, type 2 diabetes, and metabolic syndrome.

References

1. Merritt JL 2nd et al. - Biochemical and clinical overview of fatty acid oxidation disorders. Journal of Inherited Metabolic Disease, 2018. PMID: 29327212.
2. Spiekerkoetter U. et al. - Diagnostics and therapy of inborn errors of fatty acid oxidation. Monatsschrift Kinderheilkunde, 2011.
3. Newborn Screening: Towards a Global Policy. World Health Organization (WHO), Geneva, 2021.